Skip to Content


Genomic Medicine Program Advisory Committee; Notice of Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

The Department of Veterans Affairs (VA) gives notice under Public Law 92-463 (Federal Advisory Committee Act) that the Genomic Medicine Program Advisory Committee will meet on May 21, 2010, at the Westin Washington, DC City Center, 1400 M St., NW., Washington, DC. The meeting will convene at 9 a.m. and adjourn at 5 p.m. The meeting is open to the public.

The purpose of the Committee is to provide advice and make recommendations to the Secretary of Veterans Affairs on using genetic information to optimize medical care of Veterans and to enhance development of tests and treatments for diseases particularly relevant to Veterans.

The Committee will receive program updates from the VA program staff; continue to discuss optimal ways for VA to incorporate genomic information into its health care program while applying appropriate ethical oversight and protecting the privacy of Veterans; presentations on genomic medicine delivery within VHA and proof of concept for genome-phenome associations using the electronic health record; an overview of an upcoming large scale study on the genetics of functional disability of mental illness; and a roll-out of the national genomics initiative, the Million Veteran Program.

Public comments will be received at 3:45 p.m. Public comments will be limited to five minutes each. Individuals who speak are invited to submit 1-2 page summaries of their comments at the time of the meeting for inclusion in the official meeting record. Any member of the public seeking additional information should contact Dr. Sumitra Muralidhar, Designated Federal Officer, at

Start Signature

Dated: May 7, 2010.Start Printed Page 26847

By Direction of the Secretary.

Vivian Drake,

Acting Committee Management Officer.

End Signature End Preamble

[FR Doc. 2010-11322 Filed 5-11-10; 8:45 am]